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1. INTRODUCTION, LITERATURE REVIEW 
 
 
1.1. Ethylene oxide 
 
Ethylene oxide (ETO) is one of the most important epoxide compounds that is widely used 
in the industry. ETO is a well-known mutagen; its carcinogenicity is confirmed by animal 
studies and suggested by human epidemiological investigations. The International Agency for 
Research on Cancer (IARC) has found evidence on the carcinogenic property of ethylene 
oxide and classified it as “carcinogenic to humans” (Group 1).  
 
1.1.1. Characteristics, exposure 
Ethylene oxide (C2H4O) is a colourless gas with ether-like sweet odour. It has high reactivity 
due to its cyclic ether molecular structure. The highly flammable ETO is a widely used 
intermedier of the chemical industry. Based on its antimicrobial property ETO is applied as a 
cleaner, disinfectant and sterilizer. The food industry uses it for the fumigation of food 
products, and the health care for the sterilization of medical equipment.  
Human exposure can be experienced predominantly by inhalation in occupational settings, 
occurring mainly during ethylene oxide production in chemical industry, use in plastic 
industry, ETO sterilization in food, medical and pharmaceutical industry, and in the 
sterilization units of hospitals. Operators of ETO gas sterilizers are typically exposed to ETO 
levels between 0.1–20 mg/m3 8-hour-time-weighted-average in hospitals. The highest 
exposure levels (even several thousand mg/m3) can be encountered at the end of process when 
the door of sterilizer is opened and the gas is released, as well as when the cylinders are 
changed; and it can be attributed to improper design, maintenance and use of the equipment. 
The air concentration of ETO was observed in a range of 5–150 mg/m3 in the resting room of 
nurses of a Hungarian county hospital, where the gas sterilizer was run anomalously between 
1976–1992.  
 
1.1.2. Acute and chronic health effects 
Ethylene oxide has considerable acute toxicity. It can strongly irritate the skin and mucus 
membranes with local acute effect. Systemically it often causes general symptoms, in serious 
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cases incoordination and speaking difficulty may develop. High doses of ETO induce 
pulmonary oedema and narcosis.  
Chronic ETO exposure results in cataract formation. It can cause chronic inflammation of 
the respiratory tract, dermatitis and skin sensitization. Chronic exposure may lead to damage 
of the liver, peripheral and central nervous system. Embryotoxicity and teratogenicity are late 
toxic effects of ETO. The frequency of abortions increases among females exposed to 
ethylene oxide at the workplace; decreased male fertility has also been observed.  
 
1.1.3. Genotoxicity, mutagenicity, carcinogen effects 
Ethylene oxide is a directly acting alkylating agent, similarly to other epoxide compounds. 
Due to its high reactivity, ETO easily forms adducts with cellular macromolecules, such as 
DNA and proteins. ETO can alkylate the amino acid side chains of some proteins (e.g. 
haemoglobin), as well as the bases (purine) and phosphate groups of DNA. The modification 
affects predominantly N-7-guanine resulting in the formation of N-7-alkyl(hydroxyethyl) 
guanine. As a consequence, the glycosyl bound between the guanine base and the deoxyribose 
ring becomes destabilized leading to spontaneous base loss. Furthermore, the activity of N-
glycosylases specialised to modified bases also contributes to the increasing number of 
apurinic sites.  
The genotoxic and mutagenic properties of ETO has been demonstrated by several in vitro 
tests, in vivo animal and human epidemiological studies. ETO provided positive results in the 
Salmonella typhimurium Ames reverse mutation assay with some strains. It was found to 
induce DNA strand breaks, hypoxantine(guanine) phosphoribosyl transferase (HPRT) gene 
mutations and sister-chromatid exchange in cell cultures; HPRT mutations, chromosome 
aberrations, micronucleus formation and sister-chromatid exchange in animals in vivo; and 
DNA strand breaks, chromosome aberrations and sister-chromatid exchange in humans.  
Although, inhaled ethylene oxide induced several types of cancer in animal experiments, 
epidemiological studies provided inconclusive findings about its carcinogenic properties in 
humans. The potential role of ETO exposure in the development of breast cancer has been 
suggested by Norman et al., however, this hypothesis is still questionable. Besides its 
acknowledged potency in causing leukaemia and lymphoma, some studies identified 
additional types of tumours induced by ETO in humans, such as breast cancer, while others 
yielded negative results. 
An unusual cluster of cancer cases, including several cases of breast cancer, has been 
identified among health care workers of the Markhot Ferenc Hospital in Eger. On the basis of 
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the increased incidence of neoplastic diseases, Tompa et al. conveyed the suggestion that it 
might be related to occupational exposure to ETO from an inappropriately run gas sterilizer. 
Elevated levels of chromosome aberrations and sister-chromatid exchange could be detected 
in the peripheral blood lymphocytes of exposed individuals. The hypothesized etiological role 
of ETO in breast cancer induction was also supported by an epidemiological study based on 
indirect standardisation from Kardos et al., who demonstrated excess mortality rates (SMR: 
251–273%) with strong statistical significance in the exposed hospital cohort. 
 
1.1.4. Occupational health aspects of carcinogenicity 
In virtue of the Chemical Safety Act 2000 (XXV.), the 25/2000. EüM-SzCsM Regulation 
defines maximal concentration (MK) level to the chemicals with stochastic effect – typically 
carcinogens that no-observed-adverse-effect-level cannot be established for –, which must not 
be exceeded at workplaces for any time. MK level for ETO is 1,8 mg/m3 (1 ppm) in Hungary. 
The binding occupational exposure level (permissible exposure limit, PEL) for ethylene oxide 
set by the US. Occupational Safety and Health Administration is the same as that applied in 
Hungary (1,8 mg/m3), however, the maximum exposure level (MEL) in the United Kingdom 
is higher (10 mg/m3).  
 
 
1.2. Comet assay 
 
The measurement of DNA damage in individual cells was realised by Östling and Johanson 
who developed the single-cell gel electrophoresis assay (comet assay). Further improvement 
of the comet assay was carried out by Singh et al. by introducing alkaline conditions of DNA 
unwinding and electrophoresis allowing the detection of not only double- but also single-
strand breaks and alkali labile sites (apurinic, apyrimidinic sites and phosphotriesters). In the 
last decade, several versions of the technique were developed for the identification of various 
types of DNA damage (e.g. oxidative).  
 
1.2.1. Method, application 
The alkaline version of the comet assay is a sensitive and simple method for detecting DNA 
single and double strand breaks and alkali labile sites. After the cytoplasm of examined cells 
embedded in agarose on microscope slides is lysed in alkaline solution with high salt and 
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detergent content, the double helix structure of DNA in the remaining nuclei is allowed to 
unwind and break up under alkaline conditions. In this way, single-strand breaks, even alkali 
labile lesions, capable of being transformed into single-strand breaks at high pH, become 
detectable. During electrophoresis, the intact large DNA molecule remains sedentary in the 
low voltage electric field, while the damaged, broken peaces migrate towards the anode. The 
size of the evolved „tail” (the extent of migration) is proportion to the level of DNA damage.  
A useful application of the alkaline comet assay is the field of genetic toxicology. Several 
studies used the method to investigate the genotoxic properties of various chemicals in vitro 
and in vivo. A great advantage of the assay is its sensitivity and that only a few cells and a 
small quantity of test chemical are needed. Due to its sensitivity, the comet assay also proved 
to be a useful technique in epidemiological studies, mainly for the detection of DNA damage 
in cells from samples of individuals exposed to genotoxic agents.  
 
1.2.2. Genotoxicological studies with hexavalent chromium 
The in vitro model for investigating the genotoxic effect of ethylene oxide was developed in 
our previous study with hexavalent chromium (CrVI). CrVI, classified by the IARC as 
“carcinogenic to humans”, exposes humans predominantly by inhalation. Since the principal 
biological target is the respiratory tract, a confluent layer of human lung cells provided 
adequate in vitro model for the investigation of the genotoxic effect of CrVI exposure. We 
characterised the DNA damaging effect of CrVI in two cell populations, i.e. in cultures of 
peripheral lymphocytes and alveolar type II pneumocytes (A549 human epithelial lung 
carcinoma cell line; ECACC No. 86012804). The treatment of cells with non-cytotoxic 
concentrations of sodium dichromate resulted in a concentration-dependent increase of the 
genotoxic effect as measured by the alkaline version of the comet assay. The lowest 
concentrations of sodium dichromate that resulted in a statistically significant (p<0.01) 
increase of the DNA damage level were 50 μM in lymphocytes and 10 μM in pneumocytes. 
Endonuclease (formamidopyrimidine glycosylase) pre-treatment that makes the comet assay 
able to detect oxidative type DNA damage increased the sensitivity of detection in 
pneumocytes 10-fold, suggesting a role for DNA base oxidation in the mechanism of DNA 
damage induced by hexavalent chromium. The plateau observed at high concentrations of the 
dose-response curve (1 mM) suggests the formation of DNA-DNA cross-links induced by 
CrVI exposure. The model developed for investigating the genotoxicity of hexavalent 
chromium proved to be adequate for the investigation of ethylene oxide.  
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2. OBJECTIVES 
 
 
The objective of our study was to investigate the genotoxic effects of ethylene oxide in vitro 
in primary and secondary cell cultures.  
The sensitivity of breast epithelial cells was characterised by comparing the sensitivity of 
known and hypothesized target cells of ethylene oxide and also that of cell types not identified 
as targets, in order to answer the question whether ethylene oxide exposure can be responsible 
for breast cancer development.  
 
In the study we investigated:  
 
1. Is it possible to set up an in vitro laboratory model, by which the DNA damage induced by 
treatment with ethylene oxide can be measured by means of the comet assay in human cell 
cultures? 
 
2. Is there a statistically demonstrable difference in the susceptibility of the various cell types 
studied that can be characterised by the dose-response relationship of genotoxicity?  
 
3. Are the breast epithelial cells similar to those cells that are susceptible to the genotoxic 
effect of ethylene oxide? 
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3. MATERIALS AND METHODS 
 
 
3. 1. Cell cultures 
 
Human lymphoblasts (HL-60 human promyelocytic leukaemia cell line; ECACC No. 
93021013) were cultured in RPMI 1640 medium supplemented with 20% foetal bovine serum 
(FBS). The adherent cells were grown as a monolayer: the human breast epithelial cells (BT-
474 human epitheloid ductal breast carcinoma cell line; ATCC No. MTB-20) in RPMI 1640 
medium (supplemented with 20% FBS), and the human keratinocytes (HaCaT spontaneously 
transformed human keratinocyte cell line; Deutsches Krebsfroschungszentrum, Heidelberg) 
and cervical epithelial cells (HeLa human epitheloid cervical carcinoma cell line; ECACC No. 
93021013) in DMEM medium (supplemented with 10% FBS). All cell lines were cultured in 
25 cm2 plastic cell culture flasks in the humidified 5% CO2 atmosphere of an incubator at 
37°C.  
Human blood samples were repeatedly obtained from the same healthy, non-smoking male 
volunteer and processed immediately. After separation, peripheral lymphocytes were 
suspended in RPMI 1640 medium supplemented with 10% FBS. 
The Trypan-blue exclusion test was used throughout the study to assess cell viability by 
detecting membrane integrity. The viability of isolated cells was found to be always over 
90%. The passages and all other handling of cells were carried out in a class II 
microbiological safety cabinet with appropriate hygiene measures. 
 
 
3.2. Ethylene oxide exposure 
 
Stock solutions of ethylene oxide (1 M) were freshly prepared before each experiment by 
weighing liquid state ETO (boiling-point 10.4°C) into PBS (pH 7.5) in glass screw-cap vials 
with septa at 4°C using a gas-tight pre-cooled syringe. Dilutions were made from the stock 
solution in the culture media.  
The cells were treated with ethylene oxide and further processed in a system that we 
developed earlier for the in vitro characterisation of genotoxic properties of hexavalent 
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chromium. The applied concentrations (0–1000 μM) were defined after pre-testing the 
cytotoxic effect of ETO with the Trypan-blue exclusion test. During the cytotoxicity studies 
the proportion of viable cells was found to be always >85% in the 0–1000 μM concentration 
range.  
Lymphoblasts and peripheral lymphocytes were treated at a cell density of 2 x 105 cells/ml 
medium in plastic tubes at 37°C for 1 hour. The adherent breast epithelial cells, keratinocytes 
and cervical epithelial cells were seeded in 12-well plates and grown to confluence before 
treatment with ethylene oxide in medium at 37°C for 1 hour. 
After treatment and removal of the medium, adherent cells were scraped up from the wells to 
avoid trypsin induced DNA damage. The medium was separated by centrifugation from the 
cells treated in suspension. All cell cultures were then washed and re-suspended in serum-free 
medium at a cell density of 1000 cells/μl for use in the comet assay.  
Each experiment was repeated 3–6 times. Cell viability was determined before and after 
treatment by use of the Trypan-blue exclusion test and the proportion of dead cells did never 
exceed the values found in the investigation of cytotoxicity.  
 
 
3.3. Comet assay 
 
For the assessment of genotoxicity, the alkaline version of the comet assay was used with 
the following modifications: 1% normal melting-point agarose (NMA) was cast on the surface 
of a one-sided fully frosted microscope slide, and then after solidification removed in order to 
provide better surface adhesion and to substantially reduce background intensity. Then a new 
1% NMA layer was cast on the surface. Cells (∼10000–15000) were embedded in 0.75% low 
melting-point agarose (LMA) applied on the 1% NMA layer and covered with a top 0.75% 
LMA layer. After solidification, slides were placed in a cold lysis solution overnight. Further 
steps were made in a darkroom at yellow light in the absent of sunlight. After the lysis of 
cytoplasm, the unwinding of DNA and the breaking off of abasic lesions was allowed for 20 
minutes in an alkaline electrophoresis buffer (pH>13). The electrophoresis was conducted in 
the same buffer in a horizontal electrophoresis tank for 20 minutes at room temperature by 
applying an electric current of 0.8 V/cm (300 mA). Slides were then immersed in a 
neutralization buffer for 3×5 minutes, dried and stained with ethidium bromide solution. 
Duplicated slides were used for each sample. 
 7
Digitalisation and analysis of the fluorescent images was carried out with a Zeiss Axioplan 
fluorescent microscope equipped with a 50 W mercury-arc lamp, connected to a black-and-
white intensified charge-coupled device camera and a comet image-analysis system 
(Metasystems, Germany). Applying a multi-bandpass filter system, the samples were excited 
at 570 nm. Images of 50 randomly selected nuclei/slide (100 images/sample) were digitally 
captured at 400× magnification, using a 40× NA 0.75 dry objective.  
DNA damage was measured and expressed as tail DNA (% of intensity) and tail length 
(μm), from which tail moment values (tail moment = tail DNA content (%)×tail length) were 
automatically calculated with the ‘Comet Imager 1.2’ software. After correction to the 
background intensity, the measurement programme of the image-analysis software set the 
intensity curve for the whole image and then the intensity of the head was determined by 
mirroring the curve to the point of highest intensity. The difference of the curves provided the 
tail intensity. In case the automatic measurement process did not work properly due to the 
asymmetric shape of the comet head, manual image-analysis was allowed by identifying the 
area of the head manually after marking out the object and adjusting the threshold of intensity.  
 
 
3.4. Statistical analysis 
 
Mean values of DNA damage induced by various doses of ethylene oxide in repeated 
experiments were compared to the baseline data of untreated cells by Student’s t-test, since 
the means followed normal distribution (determined with the Skewness and Kurtosis test for 
normality). Significance was accepted at a 5% significance level (p<0.05).  
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4. RESULTS 
 
 
4.1. Ethylene oxide cytotoxicity 
 
The viability of investigated cell types was found to be over 85% in the 0–1000 μM 
concentration range of ethylene oxide measure by Trypan-blue test, but it was significantly 
reduced at 5 mM. We could deduct to the viability of cells from the results of the comet assay, 
too, since it is an experimental phenomenon that tail DNA (TD) increases considerably in a 
dead (apoptotic) cell population (cell death is probable at 60%–80% and unambiguous over 
80%). Based on this observation, we could also conclude that opposed to the range of  
0–1000 μM, treatment with a 5 mM concentration was absolutely cytotoxic in breast 
epithelial cells (TD 82.68%) and lymphoblasts (TD 88.24%), and partially in the other cells 
types.  
 
 
4.2. Ethylene oxide genotoxicity 
 
The genotoxic effect of ethylene oxide in various human cell lines was analysed by 
comparing the dose-response curves of DNA-damage parameters. A statistically significant 
increase of tail moment (TM), tail DNA and tail length (TL) values was observed in the  
0–100 μM concentration range, which could be statistically confirmed by demonstrating a 
significant increase compared with the baseline values measured in untreated cells.  
Similar dose-response curves were characteristic for the cultures of keratinocytes and 
cervical epithelial cells. Only a minimal elevation could be observed up to a treatment 
concentration of 50 μM ethylene oxide compared with the DNA damage levels of untreated 
cells (in keratinocytes TM 1.94, TD 12.88%, TL 13.9 μm; in cervical epithelial cells TM 2.17, 
TD 11.6%, TL 11.75 μm); and a considerable increase was only detectable in the 50–100 μM 
range. The maximum damage observed in the studied concentration range was the smallest 
for these cultures in comparison with that of other cell types studied (about 2-fold increase in 
TM, 1.5-fold in TD and TL values). A statistically significant increase of DNA damage was 
induced by 50 μM ethylene oxide in tail moment and tail DNA values (TM 2.39 and 2.54, 
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p<0.05; TD 15.78% and 12.08%, p<0.05, respectively), and by 100 μM in tail length values 
(14.76 μm, p<0.05 and 19.6 μm, p<0.01, respectively).  
Low levels of DNA damage were characteristic in untreated human peripheral lymphocytes, 
compared with the other cell types (TM 1.23, TD 8.57%, TL 10.12 μm). Dose-response 
curves of the parameters measured were close to linear and the values showed the highest 
increase in the 0–100 μM concentration range among the studied cell types (more than 4-fold 
in TM, 2-fold in TD and TL values). The lymphocytes had significantly increased DNA 
damage measured in tail moment and tail DNA after treatment with 20 μM ethylene oxide 
(TM 2.11, p<0.001; TD 11.09%, p<0.01), and after 50 μM treatment when damage was 
expressed as tail length values (TL 17.59 μm, p<0.05).  
Breast epithelial cells and lymphoblasts showed similar increase of DNA damage related to 
the levels of untreated cells (in breast epithelial cells TM 2.77, TD 12.01%, TL 16.74 μm; in 
lymphoblasts TM 2.04, TD 13.19%, TL 13.28 μm), induced by exposure to ethylene oxide. 
The increase of tail moment in the 0–100 μM concentration range was quite substantial (3-
fold); the tail DNA and tail length values also produced a similar (more than 1.8-fold) 
increase in both cell types. Compared to the untreated cells, significant elevation of the DNA 
damage level could be observed in both cell lines treated with 20 μM ethylene oxide 
considering the tail moment and tail length parameters (TM 3.33 and 3.09, p<0.05; TL 21.24 
μm and 18.72 μm, p<0.05, respectively). The tail DNA values of breast epithelial cells and 
lymphoblasts increased significantly after treatment with 50 μM ethylene oxide (TD 20.26%, 
p<0.01 and 18.21% p<0.05, respectively). 
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5. DISCUSSION 
 
 
Ethylene oxide is a well-known mutagen and carcinogen; however, the number of in vitro 
studies regarding its genotoxic effect is limited compared with that of other carcinogenic 
compounds of similar importance. Only one study investigated the DNA-damaging effect of 
ethylene oxide by means of the – among others –comet assay so far. However, the subjects of 
exposure were in vitro cultures of human fibroblasts that can not be considered as targets of 
ETO genotoxicity and the results were visually evaluated. The primary goal of using the 
method was not the characterisation of DNA damage but the examination of its distribution 
among the cells.  
The aim of our studies was to investigate the DNA-damaging effect of ethylene oxide in 
vitro in human breast epithelial cells, lymphoblasts, peripheral lymphocytes, keratinocytes 
and cervical epithelial cells by characterising cytotoxicity and dose-response relationships. 
Selection of cell types was determined by practical aspects of human exposures. The reason 
for investigating lymphoblasts was the demonstrated phenomenon that human exposure to 
ETO induces predominantly leukaemia and lymphoma. The examination of breast epithelial 
cells was motivated by the hypothesis that these cells may also be targets of ETO exposure, 
which was assumed by the observed relationship between the breast cancer cases among 
health care workers of the Markhot Ferenc Hospital in Eger and their exposure to ethylene 
oxide. Peripheral lymphocytes were selected in the study because this easily obtainable cell 
population is used for monitoring early response to genotoxic effects in practice. 
Keratinocytes and cervical epithelial cells provided base of comparison for the study, since 
development of skin or cervical cancers in relation with ETO exposure had not been reported 
yet.  
The site specificity of ethylene oxide as a carcinogen is the subject of intense speculation. 
The most frequently observed types of neoplasm associated with exposure to ETO are 
haematological malignancies. Based on epidemiological findings, the development of breast 
cancer induced by occupational exposure to ethylene oxide has been suggested by Norman et 
al., and Steenland et al. have also found recently some evidence of a positive dose-response 
relationship between ETO exposure and breast cancer mortality. However, other studies have 
not supported this assumption. Müller and Bertók have published data supporting the role of 
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ethylene oxide in the development of breast cancer in Hungary. This presumption was later 
confirmed by the findings of epidemiological and in vivo genotoxicity studies, as well. The 
results of our investigations provide further support – although no primary evidence – that 
exposure to ethylene oxide may contribute to the induction of breast cancer.  
We observed the induction of pronounced DNA damage in breast epithelial cells treated 
with 20 μM ETO, which was similar to the effect seen in lymphoblasts and in peripheral 
lymphocytes. Keratinocytes and cervical epithelial cells were significantly less susceptible to 
the effect of ETO, i.e. their tail moment and tail DNA values increased significantly only at 
doses ≥50 μM. Moreover, these cells had significantly increased tail length values only when 
they were treated with 100 μM ETO.  
Our investigations found increased DNA damage at lower ethylene oxide concentrations 
than those reported in studies that analysed other endpoints. This could be due to the high 
sensitivity of the comet assay. In earlier studies, a significant increase of DNA damage was 
observed upon treatment of human fibroblasts with 2.5 mM ETO in the HPRT mutagenicity 
test and in the alkaline DNA unwinding method, respectively. By use of the alkaline elution 
technique, DNA damage was observed at 1 mM ETO exposure in human peripheral 
lymphocytes and at 0.5 mM in Chinese hamster ovary cells. There are no reliable human data 
for the inner those of ethylene oxide, the values can be estimated only by extrapolating results 
of animal studies. An approximate inner dose of ETO was calculated by Beliles and Parker 
using toxicokinetic data from animal studies. When exposed to 1.8 mg/m3 (1 ppm) air 
concentration of ETO for 8 hours, the area under the concentration–time curve in the blood 
plasma of a person was estimated to be 18.8 μg×h/ml (426 μmol×h/l) on the basis of data 
from experiments with rats and 14.3 μg×h/ml (324 μmol×h/ml) on the basis of data from 
dogs. The extrapolation of animal data to humans has its limitations, and the internal dose 
does not necessarily correspond to the biologically effective dose. Nevertheless, it can be 
concluded from the above data that low ETO concentrations applied in our study might 
represent more accurately the plasma levels in exposed individuals than high doses used 
earlier.  
The increase of DNA damage levels was highest in peripheral lymphocytes in the 0–100 μM 
concentration range among the cell types studied, especially when measured as tail moment 
(4.3-fold). It is assumed that the low DNA-damage level in untreated cells may be the reason 
for the pronounced increase, since the absolute values of DNA damage in the non-dividing 
peripheral lymphocytes are mostly less than in lymphoblasts or breast epithelial cells. The 
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standard deviation of mean values from repeated experiments is high compared with that of 
other cell types due to the varying proportions of susceptible cell groups present in the 
heterogeneous population of lymphocytes, which may also contribute to the considerable 
increase of DNA damage. The response to the genotoxic impact of ETO in the important 
lowest concentration range (0–50 μM), which is the most characteristic for real exposure 
situations, did not differ considerably between breast epithelial cells, lymphoblasts and 
peripheral lymphocytes, therefore similar susceptibilities for these cell types may be assumed. 
A significant DNA-damaging effect induced by low concentrations of ethylene oxide could 
not be observed in keratinocytes and cervical epithelial cells, indicating explicitly a lower 
susceptibility of these cells towards the genotoxic effect studied than that of the other cell 
types investigated. This finding was supported by the slow increase of DNA damage in the  
0–100 μM dose range, as well as by the high concentrations of ETO necessary to induce a 
significant genotoxic effect in keratinocytes and cervical epithelial cells.  
The susceptibility of human lymphoblasts and breast epithelial cells was similar. This 
supports the assumption that breast epithelial cells are targets of the DNA damage induced by 
ethylene oxide exposure, just like bone marrow cells. A great advantage of the in vitro model 
applied is the provision of controlled laboratory conditions that vary only in the treatment 
doses; however, the extrapolation of our results to in vivo conditions needs to be considered 
with caution, since no real exposure situations were studied. ETO is a subject for both 
spontaneous and enzymatic decomposition in the human body. Therefore if the respiratory 
system is the portal of entry, it may be assumed that the ethylene oxide concentration reaching 
epithelial cells in the breast – the biologically effective dose – is lower than that affecting 
lymphocytes and cells of the bone marrow rich in blood vessels, or the dose exposing gastric 
mucosa in case of gastrointestinal intake. Further in vivo studies are hence needed to elucidate 
the toxicokinetic properties of ethylene oxide.  
Determination of the lowest ethylene oxide concentration that can induce significant DNA 
damage detectable by means of the comet assay has the occupational health importance of 
providing help with additional information for the establishment or modification of 
occupational exposure limits.  
The comet assay is a sensitive however, not specific method for the detection of DNA 
damage. The different types of damage cannot be distinguished by the results of 
measurements, only deduced indirectly. Certainly, this method can also not specify the 
genotoxic agent; therefore the consideration of possible confounders has great practical 
importance. Notwithstanding, detection of DNA damage by means of the comet assay in 
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human peripheral lymphocytes, isolated from the blood of workers exposed to ethylene oxide 
or other DNA damaging agents, may become a helpful component in the biomonitoring of 
early response to genotoxic insults, contributing to a better assessment of individual risk.  
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6. CONCLUSIONS AND RECOMMENDATIONS 
 
Conclusions: 
 
1. Ethylene oxide induces dose-dependent DNA damage detectable by means of the comet 
assay in human breast epithelial cells, lymphoblasts, peripheral lymphocytes, 
keratinocytes and cervical epithelial cells in the concentration range of 0–1000 μM in the 
absence of cytotoxicity.  
2. The susceptibility of human breast epithelial cells, lymphoblasts and peripheral 
lymphocytes towards the genotoxic impact of ethylene oxide is not different essentially 
and significantly higher than that of keratinocytes and cervical epithelial cells.  
3. Human breast epithelial cells, similarly to lymphoblasts and peripheral lymphocytes, may 
be target cells of exposure to ethylene oxide.  
4. Detection of DNA damage induced by ethylene oxide in peripheral lymphocytes by means 
of the comet assay offers a potential biomarker applicable in occupational health 
investigations.  
5. The cell lines used in our studies provide suitable in vitro models to further investigation 
of the genotoxic properties, effect mechanisms of ethylene oxide.  
 
Recommendations: 
 
1. Further studies can be carried out for the thorough characterisation of ethylene oxide 
genotoxicity with the applied cell lines as in vitro models.  
2. Detailed elucidation of the toxicokinetic properties of ethylene oxide is necessary for the 
accurate extrapolation of in vitro results to true exposures.  
3. Further studies are required to assess the feasibility of using the comet assay to early 
detection of DNA damage induced by occupational genotoxic exposures.  
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